:: Library Catalog

Imagen de Portada

Guardado en:

Detalles Bibliográficos
Autores principales:	Nastiti Faradilla Ramadhani, Aga Satria Nurrachman, Eha Renwi Astuti, Otty Ratna Wahjuni, Yunita Savitri, Sri Wigati Mardi Mulyani, Deny Saputra, Ramadhan Hardani Putra, Alhidayati Asymal, Dwi Siti Lativa, Hana Atsarina Imtinan
Formato:	Recurso digital
Lenguaje:	inglés
Publicado:	Zenodo 2024
Materias:	Convalescent plasma COVID-19 Immunotherapy Infectious diseases
Acceso en línea:	https://doi.org/10.5281/zenodo.14723913
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Convalescent plasma transfusion of COVID-19 patients: Proposal from the Peruvian Immunology Society and the Peruvian Medical Association of Clinical Pathology for its implementation in our country
por: Galvan, Cesar Alberto, et al.
Publicado: (2020)

HYPOTHYROIDISM DURING ONCOLOGY PROTOCOLS: A REPORT ON THREE CASES
por: Rania Dassoufi, et al.
Publicado: (2025)

Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors
por: Rita Nader
Publicado: (2021)

Construction of a model for predicting the prognosis of liver cancer patients based on CuProtosis-related LncRNA
por: Yiyang Chen
Publicado: (2023)

Consecuencias económicas en la vida real de la inmunoterapia con alérgenos en asma, rinitis y dermatitis
por: Jorge Sánchez
Publicado: (2016)

Potentiating immunotherapy in "immune-cold" solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering.
por: He, Jiaqi, et al.
Publicado: (2025)

Decoding melanoma's cellular mosaic to unlock immunotherapy potential.
por: Pozniak, Joanna, et al.
Publicado: (2025)

A Comprehensive Treatment-Induced Resistance Atlas of Glioblastoma Reveals a Fibrotic Niche Shielding the Tumor from Immunotherapy
por: Wang, Fei
Publicado: (2025)

Immunotherapy and Complexity: Overcoming Barriers to Control of Advanced Cancer
por: Agustin Lage
Publicado: (2014)

Advances in Lung Cancer: Diagnostics, Molecular Pathways, and Emerging Therapeutic Strategies
por: Ashok Bendgude, Shubham Patil, Siddhi Shirahatti, Disha Fartade, Ajit Patil, Anilkumar Shinde
Publicado: (2026)

Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy.
por: Sheykhhasan, Mohsen, et al.
Publicado: (2025)

A review on the evolution of immunotherapy in bladder carcinoma
por: Milena Gulinac
Publicado: (2020)

Mapping intratumor heterogeneity across layers for advancing immunotherapy.
por: Marine, Jean-Christophe, et al.
Publicado: (2026)

Live Bacteria Therapy for TB Immunotherapy Using Ag85AB as Vector and Targeted Liposome Delivery system
por: Amimo, Lesley, et al.
Publicado: (2026)

Bacterial Foreignization Nanosystem Elicits Multi-Phenotypic T Cells for Antitumor Immunity.
por: Zhuang, Wan-Ru, et al.
Publicado: (2025)

Adult B-cell acute lymphoblastic leukaemia antigens and enriched pathways identify new targets for therapy
por: Mohamed, Eithar, et al.
Publicado: (2025)

Immunocompetent tumor-on-a-chip: A translational tool for drug screening and cancer therapy.
por: Liang, Anqi, et al.
Publicado: (2025)

Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype.
por: Pozniak, Joanna, et al.
Publicado: (2025)

State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues.
por: Praveena, T, et al.
Publicado: (2024)

Lysosome-Mitochondria Cascade Targeting Nanoparticle Drives Robust Pyroptosis for Cancer Immunotherapy.
por: Liu, Jianxiong, et al.
Publicado: (2024)

Self-Carrier Nanoagonist Enabling Positive Feedback Regulation of Cuproptosis-Immunity for Potent Antitumor Therapy.
por: Jiang, Minhao, et al.
Publicado: (2026)

Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer.
por: Lin, Pei-Hsuan, et al.
Publicado: (2026)

Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment.
por: Lodi, Francesca, et al.
Publicado: (2025)

Linitis Plastica and colonic obstruction: A comprehensive review of clinical challenges and outcomes
por: Mohtashami, Ali, et al.
Publicado: (2025)

Targeted GPX4 Degradation Mediated by Hypoxia-Overcoming Nano-PDTACs for Synergistic Ferroptosis-Immunotherapy.
por: Ji, Rui, et al.
Publicado: (2026)

An Endoplasmic Reticulum Stress-Specific Nanoinducer Selectively Evokes Type-II Immunogenic Cell Death for Pyroptotic Cancer Immunotherapy.
por: Zhang, Yimeng, et al.
Publicado: (2025)

Immune checkpoint inhibitors in Brazil: regulatory approval and public procurement within the Unified Health System
por: Viana Pereira, Debora Cristina, et al.
Publicado: (2026)

Photoimmunotherapy using indocyanine green-loaded Codium fragile polysaccharide and chitosan nanoparticles suppresses tumor growth and metastasis.
por: Ryu, Dayoung, et al.
Publicado: (2024)

Cytochalasin Z16 reshapes macrophage responses to intracellular pathogens: HSPA5-targeted immunotherapy against zoonotic and foodborne Edwardsiella tarda.
por: Shi, Jin-Jin, et al.
Publicado: (2026)

Preliminary Insights Into the Combined Antitumor Efficacy of Onco-VV-TT and Natural Killer Cells in Glioblastoma.
por: Mirbahari, Seyedeh Nasim, et al.
Publicado: (2026)

Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.
por: Xiong, Jieyi, et al.
Publicado: (2025)

Use of convalescent plasma in COVID-19 patients
por: Nelson M. Nina Garcia
Publicado: (2020)

Treatment of chronic COVID‐19 with convalescent/postvaccination plasma in patients with hematologic malignancies
por: Maike Janssen, et al.
Publicado: (2024)

Avidity maturation of anti‐spike IgG after vaccination in COVID‐19 convalescent vs COVID‐19 naïve patients
por: Emma Löfström, et al.
Publicado: (2024)

Aislamiento y caracterización de un fragmento de anticuerpo VNAR neutralizante de PD-L1 como herramienta para la inmunoterapia de distintos tipos de cáncer
por: Keily Naomi Del Aguila Velasco
Publicado: (2026)

Critical Issues in Head and Neck Oncology
Publicado: (2023)

Critical Issues in Head and Neck Oncology
Publicado: (2025)

Experiences in the use of multiple doses of convalescent plasma in critically ill patients with COVID‐19: An early phase 1 descriptive study
por: Ricardo Aguilar, et al.
Publicado: (2024)

Dynamics of serum cross‐neutralization capacity against SARS‐CoV‐2 Delta variant in convalescent COVID‐19 patients
por: Iulia Nedelcu, et al.
Publicado: (2024)

Absolute $\mathbb{Z}/2$ gradings in real Heegaard Floer homology
por: Srivastava, Eha
Publicado: (2026)